RECURRENT PLASMA CELL MYELOMA

Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear

Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 9 Completed 1 Terminated 1

New drug cocktail fights back against returning blood cancer

Disease control Completed

This completed Phase 2 trial tested how well the drug ixazomib works, both alone and combined with other medications, for people with multiple myeloma that has returned after previous treatment. The study involved 165 participants and aimed to measure how many patients responded …

Matched conditions: RECURRENT PLASMA CELL MYELOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

RECURRENT PLASMA CELL MYELOMA

Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear

New drug cocktail fights back against returning blood cancer